As always, fall is a great time to be a fan of horror shows — and an equally great time to be a fan of TV procedurals — and, frankly, just a great time to be a fan of good TV. This season's biggest ...
Takeda has partnered with China's Innovent Biologics for a pair of late-stage cancer therapies, in a deal that includes an upfront payment of $1.2 billion and could be worth up to $11.4 billion. The ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback